Quick Answer
Pharmagreen Biotech Inc. reported Net Income of -$875.5 thousand for fiscal year 2022.
Pharmagreen Biotech Inc. Net Income — Annual History
| Fiscal Year | Net Income | YoY Change |
|---|---|---|
| 2022 | -$875.5K | +80.7% |
| 2021 | -$4.53M | -82.6% |
| 2020 | -$2.48M | -223.5% |
| 2019 | -$767.5K | +28.5% |
| 2018 | -$1.07M | — |
Quarterly Net Income
| Quarter Ending | Net Income | YoY | QoQ |
|---|---|---|---|
| June 30, 2023 | -$162.9K | -164.7% | -313.8% |
| December 31, 2022 | -$39.4K | -310.3% | -115.6% |
| June 30, 2022 | $251.9K | +277.1% | +124.3% |
| March 31, 2022 | -$1.04M | +67.0% | -5631.6% |
| December 31, 2021 | $18.7K | +104.5% | +113.2% |
| June 30, 2021 | -$142.2K | +89.5% | +95.5% |
| March 31, 2021 | -$3.14M | -86512.5% | -653.1% |
| December 31, 2020 | -$417.1K | -102.4% | +69.3% |
- Pharmagreen Biotech Inc. showed an increase of +80.7% in Net Income compared to the prior fiscal year.
- Over the 2018–2022 period, Pharmagreen Biotech Inc.’s net income has grown by 18.5% (from -$1.07 million to -$875.5 thousand).
- The most recent figure is from Pharmagreen Biotech Inc.’s fiscal year 2022 report (Form 10-K), filed with the SEC on January 17, 2023.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: